Progress is being made to address the wide array of neurological disorders that impact nearly one-third of Americans.
On Friday, the U.S. Food and Drug Administration announced approval of the Amplatzer PFO Occluder device. The PFO Occluder reduces the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot that passed through a patent foramen ovale (PFO), and then traveled to the brain.
Stroke triage, pediatric case studies, pediatric non-accidental trauma, recognizing street drugs, and working with special needs children are all covered in this Nov. 9 event at the Nashville Fire Department Training Academy. Event is free, but registration is required.
November 3-4 • Hilton Garden Inn
Friday, Oct. 21
Strategies for acute stroke management have changed considerably in the past two years, including two new devices for removing clots and five new studies on interventional management of stroke in 2015. Come learn about these innovations and more.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: